Cardiovascular diseases

Cardiovascular diseases (CVDs), including heart failure and stroke, are a major global health concern and the leading cause of death and disability worldwide. At Boehringer Ingelheim, we address unmet medical need by providing innovative solutions that improve the care of patients living with a range of cardiovascular health conditions including heart failure, high blood pressure (hypertension), heart attack (myocardial infarction), irregular heartbeats (atrial fibrillation), stroke and blood clots in deep veins or the lungs (deep vein thrombosis or pulmonary embolism). As part of the cardiovascular, renal and metabolic (CRM) system, cardiovascular disease can also increase the risk of developing connected conditions such as chronic kidney disease and type 2 diabetes.

Cardiovascular disease therapy areas

Hypertension

Hypertension, also known as high blood pressure, affects more than one billion people worldwide, but how can people living with this condition reduce the risk of developing interconnected diseases?

Heart failure

Heart failure affects over 60 million people worldwide and is the leading reason for people aged 65 and over being hospitalized. How can we improve outcomes for those living with heart failure and interconnected conditions?

Stroke

Stroke occurs when the blood supply to part of the brain is blocked, but what are the signs and how is care being improved for those that have had a stroke?

Other cardiovascular, renal and metabolic diseases

Kidney disease

Find out why it is crucial to test people at risk of chronic kidney disease and how preserving the kidneys protects the heart.

Metabolic diseases

Did you know that type 2 diabetes and obesity affect the metabolic system, and in turn, can impact other organs in the body?

Liver disease

Learn about metabolic dysfunction-associated steatohepatitis (MASH), how it affects the liver and how it is associated with other CRM conditions.